Cart
sales@molnova.com
NVP-BHG712 isomer
CAS No. 2245892-85-5
NVP-BHG712 isomer( —— )
Catalog No. M24025 CAS No. 2245892-85-5
NVP-BHG712 isomer shows conserved non-bonded binding to EPHA2 and EPHB4.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 1 mL x 10 mM in DMSO | 85 | In Stock |
|
| 2MG | 48 | In Stock |
|
| 5MG | 76 | In Stock |
|
| 10MG | 145 | In Stock |
|
| 25MG | 259 | In Stock |
|
| 50MG | 368 | In Stock |
|
| 100MG | 548 | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameNVP-BHG712 isomer
-
NoteResearch use only, not for human use.
-
Brief DescriptionNVP-BHG712 isomer shows conserved non-bonded binding to EPHA2 and EPHB4.
-
DescriptionNVP-BHG712 isomer shows conserved non-bonded binding to EPHA2 and EPHB4.
-
In VitroNVP-BHG712 isomer exhibits IC 50 values of 163 nM and 1660 nM for EPHA2 and EPHA4, respectively.
-
In Vivo——
-
Synonyms——
-
PathwayTyrosine Kinase
-
TargetEphrin Receptor
-
RecptorEPHA2
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number2245892-85-5
-
Formula Weight503.48
-
Molecular FormulaC26H20F3N7O
-
Purity>98% (HPLC)
-
SolubilityDMSO:50 mg/mL (99.31 mM; Need ultrasonic);H2O:insoluble
-
SMILESO=C(NC1=CC=CC(C(F)(F)F)=C1)C2=CC=C(C)C(NC3=NC(C4=CC=CN=C4)=NC5=NN(C)C=C53)=C2
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Tr?ster A, et al. NVP-BHG712: Effects of Regioisomers on the Affinity and Selectivity toward the EPHrin Family. ChemMedChem. 2018 Aug 20;13(16):1629-1633.
molnova catalog
related products
-
NVP-BHG712
NVP-BHG712 is a specific EphB4 inhibitor with ED50 of 25 nM that discriminates between VEGFR and EphB4 inhibition.
-
AWL-II-38.3
AWL-II-38.3 is a potent ephrin-A receptor (EphA3) kinase inhibitor. AWL-II-38.3 does not exhibit significant cellular activity against Src-family kinases nor against b-raf.
-
UniPR505
UniPR505 is a potent EphA2 antagonist (IC50: 0.95 μM), a novel 3α-carbamoyloxy derivative with antiangiogenic properties.
